iclaprim has been researched along with methicillin in 3 studies
| Studies (iclaprim) | Trials (iclaprim) | Recent Studies (post-2010) (iclaprim) | Studies (methicillin) | Trials (methicillin) | Recent Studies (post-2010) (methicillin) |
|---|---|---|---|---|---|
| 45 | 7 | 16 | 4,375 | 72 | 1,046 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawser, S; Islam, K; Laue, H; Lociuro, S; Seguin, A; Valensise, T | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Charrier, C; Hawser, S; Huang, DB; Le Bras, C; Noviello, S | 1 |
1 trial(s) available for iclaprim and methicillin
| Article | Year |
|---|---|
The incidence and patient outcomes of ABSSSI by iclaprim MIC values in the phase 3 REVIVE trials for treatment of acute bacterial skin and skin structure infections.
Topics: Acute Disease; Anti-Bacterial Agents; Double-Blind Method; Humans; Incidence; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2019 |
2 other study(ies) available for iclaprim and methicillin
| Article | Year |
|---|---|
Effect of human plasma on the antimicrobial activity of iclaprim in vitro.
Topics: Anti-Bacterial Agents; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Plasma; Protein Binding; Pyrimidines; Staphylococcus aureus | 2007 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |